Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
July 14, 2016
Showing 4051 - 4060 of 4930 results
JAMDA
July 7, 2016
Arousal, Attention, and an Abundance of Opportunity to Advance Delirium Care
JAMDA
July 5, 2016
Sleep Duration and Excessive Daytime Sleepiness Are Associated With Incidence of Disability in Community-Dwelling Older Adults
Although sleep disturbances are associated with disability among older adults, no longitudinal study has examined the impact of sleep assessed based on both sleep quality and quantity on incident disability. This study examined whether sleep duration and excessive daytime sleepiness were associated with in...
JAMDA
July 2, 2016
Post-acute Care Trajectories in the First Year Following Hospital Discharge After Left Ventricular Assist Device Implantation
Patients with advanced heart failure who undergo left ventricular assist device (LVAD) implantation are heavy users of post-acute care services. We sought to better describe the post-acute trajectories and burden of care transitions for this patient population.
JAMDA
July 1, 2016
Metabolic Control in Older Dependent People: Need for Improvement?
JAMDA
July 1, 2016
Reply to Letter to the Editor by R.L. Jump et al
JAMDA
June 30, 2016
Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients
To explore the relationship between polypharmacy and adverse outcomes among older hospital inpatients stratified according to their frailty status.
JAMDA
June 29, 2016
Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia
Sarcopenia was recently classified a geriatric syndrome and is a major challenge to healthy aging. Affected patients tend to have worse clinical outcomes and higher mortality than those without sarcopenia. Although there is general agreement on the principal diagnostic characteristics, initial thresholds f...
JAMDA
June 24, 2016
Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials
Acetylcholinesterase inhibitor (AChEI) and memantine are recognized drug treatments with limited clinical efficacy. Combination therapy for patients with Alzheimer disease (AD) was suggested, but the additional benefit of combination therapy is still controversial.
JAMDA
June 24, 2016